for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

U.S. court rules for Teva in migraine patent dispute with Eli Lilly

WASHINGTON, March 31 (Reuters) - Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that helps preserve its rights to the migraine drug Ajovy.

The Patent Trial and Appeal Board rejected a challenge to three Teva patents relating to Ajovy brought by Eli Lilly and Co .

Reporting by Jan Wolfe; Editing by Cynthia Osterman

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up